The case for primary salivary rhabdomyosarcoma

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Rhabdomyosarcomas in salivary glands histologically resemble skeletal muscle tumors but can occur in tissues lacking muscle.
• The cell-of-origin for these salivary gland rhabdomyosarcomas remains unclear, with possibilities including primary malignancy or metastasis.

Purpose of the Study:

• To investigate the potential cell-of-origin for rhabdomyosarcomas occurring in the parotid and submandibular glands.
• To determine if salivary gland rhabdomyosarcomas are primary tumors or metastatic lesions.

Main Methods:

• Utilized genetically engineered mouse models of rhabdomyosarcoma.
• Employed Cre-lox technology to activate specific oncogenes (Pax3:Foxo1 fusion) and tumor suppressor loss (p53) under lineage-specific promoters.
• Conducted RT-PCR and immunohistochemistry to assess promoter activity in wild-type mouse salivary glands.

Main Results:

• Rhabdomyosarcoma was induced in mouse models when specific oncogenic mutations were activated under promoters previously thought to be myogenesis-restricted.
• RT-PCR and immunohistochemistry confirmed that these myogenic-related promoters are active in normal mouse salivary gland tissue.
• Mouse rhabdomyosarcomas frequently originated in salivary glands under these experimental conditions.

Conclusions:

• The salivary gland harbors a cell-of-origin for rhabdomyosarcoma.
• The presence and activity of myogenic-related promoters in salivary tissue support the hypothesis that these non-muscle cells can give rise to rhabdomyosarcoma.